Li Zhisong, Mao Yuanyuan, Liang Lingli, Wu Shaogen, Yuan Jingjing, Mo Kai, Cai Weihua, Mao Qingxiang, Cao Jing, Bekker Alex, Zhang Wei, Tao Yuan-Xiang
Department of Anesthesiology, First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, China.
Department of Anesthesiology, New Jersey Medical School, Rutgers, State University of New Jersey, Newark, NJ 07103, USA.
Sci Signal. 2017 Jul 11;10(487):eaam5345. doi: 10.1126/scisignal.aam5345.
Changes in gene transcription in the dorsal root ganglion (DRG) after nerve trauma contribute to the genesis of neuropathic pain. We report that peripheral nerve trauma caused by chronic constriction injury (CCI) increased the abundance of the transcription factor C/EBPβ (CCAAT/enhancer binding protein β) in the DRG. Blocking this increase mitigated the development and maintenance of CCI-induced mechanical, thermal, and cold pain hypersensitivities without affecting basal responses to acute pain and locomotor activity. Conversely, mimicking this increase produced hypersensitivity to mechanical, thermal, or cold pain. In the ipsilateral DRG, C/EBPβ promoted a decrease in the abundance of the voltage-gated potassium channel subunit Kv1.2 and μ opioid receptor (MOR) at the mRNA and protein levels, which would be predicted to increase excitability in the ipsilateral DRG neurons and reduce the efficacy of morphine analgesia. These effects required C/EPBβ-mediated transcriptional activation of (euchromatic histone-lysine -methyltransferase 2), which encodes G9a, an epigenetic silencer of the genes encoding Kv1.2 and MOR. Blocking the increase in C/EBPβ in the DRG improved morphine analgesia after CCI. These results suggest that C/EBPβ is an endogenous initiator of neuropathic pain and could be a potential target for the prevention and treatment of this disorder.
神经损伤后背根神经节(DRG)中的基因转录变化有助于神经性疼痛的发生。我们报告称,慢性压迫性损伤(CCI)所致的外周神经损伤增加了DRG中转录因子C/EBPβ(CCAAT/增强子结合蛋白β)的丰度。阻断这种增加可减轻CCI诱导的机械性、热性和冷性疼痛超敏反应的发展和维持,而不影响对急性疼痛的基础反应和运动活性。相反,模拟这种增加会导致对机械性、热性或冷性疼痛产生超敏反应。在同侧DRG中,C/EBPβ在mRNA和蛋白质水平上促使电压门控钾通道亚基Kv1.2和μ阿片受体(MOR)的丰度降低,预计这会增加同侧DRG神经元的兴奋性并降低吗啡镇痛的效果。这些效应需要C/EPBβ介导的(常染色质组蛋白-赖氨酸-甲基转移酶2)转录激活,该酶编码G9a,G9a是编码Kv1.2和MOR的基因的表观遗传沉默因子。阻断DRG中C/EBPβ的增加可改善CCI后的吗啡镇痛效果。这些结果表明,C/EBPβ是神经性疼痛的内源性启动因子,可能是预防和治疗这种疾病的潜在靶点。